Protalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system PLX $1.9200 0.0300 % 1.5900 Protalix Biotherapeutics Sector : Medical Industry : Medical – Biomedical Signal Short Term Trend Long Term Trend BUY UP UP Day: 1.59% Wk: […]